Attar Eyal C.
- SEC CIK
- 0001789076
No open-market purchases or sales filed in the past year.
Current role at each company
- VOR Vor Biopharma Inc.CHIEF MEDICAL OFFICERas of Feb 18, 2025
- APRE Aprea Therapeutics, Inc.SVP, Chief Medical Officeras of Jun 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Attar Eyal C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VOR Vor Biopharma Inc.
CHIEF MEDICAL OFFICER4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 (view filing) | Feb 13 | 5 days | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −2.23K | $1.42 | −$3.16K | −1.7%126.6K after | 10b5-1 |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −2.55K | $1.37 | −$3.50K | −1.9%128.9K after | 10b5-1 |
| Dec 31, 2024 (view filing) | Dec 27 | 4 days | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −10.3K | $1.25 | −$12.9K | −11.3%81.4K after | 10b5-1 |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −14.6K | $1.39 | −$20.4K | −13.2%96.1K after | 10b5-1 |
APRE Aprea Therapeutics, Inc.
SVP, Chief Medical Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 (view filing) | Feb 28 | 1 day | Attar Eyal C.SVP, Chief Medical Officer | SSale | −36.0K | $1.73 | −$62.3K | −43.4%47.0K after | |
| Sep 20, 2021 (view filing) | Sep 16 | 4 days | Attar Eyal C.SVP, Chief Medical Officer | SSale | −16.0K | $4.68 | −$74.7K | −16.1%83.0K after |